» Articles » PMID: 36328632

Timing and Spectrum of Antibiotic Treatment for Suspected Sepsis and Septic Shock: Why So Controversial?

Overview
Date 2022 Nov 3
PMID 36328632
Authors
Affiliations
Soon will be listed here.
Abstract

Sepsis guidelines and mandates encourage increasingly aggressive time-to-antibiotic targets for broad-spectrum antimicrobials for suspected sepsis and septic shock. This has caused considerable controversy due to weaknesses in the underlying evidence and fear that overly strict antibiotic deadlines may harm patients by perpetuating or escalating overtreatment. Indeed, a third or more of patients currently treated for sepsis and septic shock have noninfectious or nonbacterial conditions. These patients risk all the potential harms of antibiotics without their possible benefits. Updated Surviving Sepsis Campaign guidelines now emphasize the importance of tailoring antibiotics to each patient's likelihood of infection, risk for drug-resistant pathogens, and severity-of-illness.

Citing Articles

Incidence of and Risk Factors for Third-Generation Cephalosporin-Resistant Bloodstream Infections in Children.

Cheng J, Liu Y, Li S, Pu K, Yang L, Tan L Infect Drug Resist. 2024; 17:543-550.

PMID: 38352624 PMC: 10863459. DOI: 10.2147/IDR.S449731.


Sepsis Stewardship: The Puzzle of Antibiotic Therapy in the Context of Individualization of Decision Making.

Ramasco F, Mendez R, Suarez de la Rica A, Gonzalez de Castro R, Maseda E J Pers Med. 2024; 14(1).

PMID: 38248807 PMC: 10820263. DOI: 10.3390/jpm14010106.


Risk of Misleading Conclusions in Observational Studies of Time-to-Antibiotics and Mortality in Suspected Sepsis.

Pak T, Young J, McKenna C, Agan A, DelloStritto L, Filbin M Clin Infect Dis. 2023; 77(11):1534-1543.

PMID: 37531612 PMC: 10686960. DOI: 10.1093/cid/ciad450.